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Abstract
Purpose To assess the impact of single pass outpatient endome-
trial biopsy in patients at the highest risk for an endometrial
cause for failed implantation; those that have failed to conceive
despite the transfer of morphologically normal euploid embryos.
Methods This is a retrospective cohort study consisting of all
patients less than 42 years old who failed their first euploid
blastocyst transfer and subsequently completed a second
transfer cycle of euploid blastocysts. Cycles were analyzed
to determine if a single pass endometrial biopsy, termed 'en-
dometrial disruption', was performed in a cycle preceding
their second embryo transfer. Transfer outcomes were ana-
lyzed and implantation rates calculated. Data analysis was
performed to compare outcomes between patients who had
endometrial disruption performed versus those that did not.
Results Two hundred ninety patients failed their first euploid
embryo transfer and subsequently completed a second euploid
embryo transfer and were included. Thirty-nine patients
underwent endometrial disruption and 251 did not. There
were no statistical differences in clinical implantation rate or
sustained implantation rate between the group with endome-
trial disruption and subjects without any intervention (Clinical
IR, 43.6 % vs. 55.0 %, p=0.13; 38.5 % vs. 42.6 %, p=0.60).
When controlling for transfer order there was no statistical
difference noted in implantation rates.
Conclusions Single pass endometrial biopsy has no impact on
endometrial receptivity in the highest risk subgroup- patient's
that have failed to sustain the transfer of morphologically nor-
mal euploid embryos- as evidenced by equivalent implantation
rates. It is possible that variations in technique may alter out-
comes and randomized trials are needed to answer this question.
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Introduction
Implantation is a complicated biochemical process but funda-
mentally there are two key factors that are essential to success-
ful implantation and establishment of a viable pregnancy: em-
bryonic competence and endometrial receptivity. Over the past
decade research has focused on embryonic factors and the se-
lection of morphologically-superior, genetically-normal blasto-
cysts for transfer [1, 2]. Now that substantial improvements in
embryonic culture and enhanced selection techniques have
been validated, there is a renewed focus on the potential rea-
sons why high-quality, chromosomally-normal blastocysts do
not always implant. If single embryo transfer pregnancy rates
with advanced selection techniques are as high as 60 %, could
the endometrium be culpable for up to 40 % of the failures [3]?
Mechanical injury to the endometrium has been purported to
enhance endometrial receptivity and improve embryo transfer
outcomes, but research utilizing this technique has focused on
either the general IVF population or those who have a history
of failed implantation [4–9]. It is well known that most failed
implantations are related to suboptimal embryo quality or
Capsule Endometrial disruption has no impact on endometrial receptivity
in the highest risk subgroup- patient’s that have failed to sustain the
transfer of morphologically normal euploid embryos- as evidenced by
equivalent implantation rates.
M. D. Werner : E. J. Forman :K. H. Hong : J. M. Franasiak :
P. A. Bergh : R. T. Scott
Robert Wood Johnson Medical School of Rutgers University,
New Brunswick, NJ, USA
E. J. Forman :K. H. Hong : P. A. Bergh : R. T. Scott
RMA of New Jersey, Basking Ridge, NJ, USA
M. D. Werner (*)
140 Allen Road, Basking Ridge, NJ 07920, USA
e-mail: mwerner@rmanj.com
J Assist Reprod Genet (2015) 32:557–562
DOI 10.1007/s10815-015-0435-0
aneuploidy. Even if endometrial disruption could enhance en-
dometrial receptivity, it would not be able to improve the ability
of non-viable embryos to implant. Patients who have previous-
ly had euploid blastocysts fail to implant would seemingly
be at the highest risk of having an endometrial cause of
failed implantation. This study seeks to address whether
endometrial disruption improves outcomes in this high-risk
population with prior failed euploid transfers.
The critical role of the endometrium during implantation is
well characterized, but its role in implantation failure is poorly
understood. A variety of factors (Matrix metalloproteinases
(MMP), Interleukin-6 (IL-6), Leukemia inhibitory factor
(LIF), Tumor necrosis factor alpha (TNF-α), Connexin 43
(Cx43), monocytes, macrophages) have been implicated as
important, but an endometrial profile that promotes implanta-
tion has not yet been identified [10]. In the quest for the iden-
tification of a supportive endometrial profile, endometrial
sampling prior to IVF has been studied. In one such analysis,
the authors noted that 11 of 12 patients conceived after the
endometrium was injured [11]. This unique finding led to
subsequent studies evaluating the role of endometrial injury
as a mechanism to enhance implantation. These studies unfor-
tunately have yielded divergent results.
Mechanical endometrial injury in the cycle preceding IVF
has been proposed to improve implantation. Local injury may
induce decidualization or provoke wound healing, attracting
cytokines, growth factors, LIF, and other immune modulators
to the area to enhance implantation [12]. Alternatively, it may
induce endometrial injury resulting in adhesions or inadequate
proliferation in subsequent cycles thereby slowing endometri-
al development and potentially causing endometrial-
embryonic dyssynchrony [13]. The investigation of endome-
trial disruption and its ultimate impact on outcome thus far has
been inconclusive. A randomized controlled trial (RCT) of
134 patients with one or more failed IVF cycles demonstrated
dramatic improvement in overall outcomes after endometrial
disruption on repeated biopsies prior to transfer [5]. In a sim-
ilar RCT, 100 patients with a history of failed IVF had endo-
metrial sampling performed twice, which significantly im-
proved the chance for live birth in the intervention group
(22.4 % vs 9.8 % P=0.04) [14]. However, a subsequent study
utilizing a sham procedure showed no improvement [15]. In
contrast, a large meta-analysis demonstrated that local endo-
metrial injury is 71 % more likely to result in a clinical preg-
nancy as opposed to no intervention [4]. In the most recent
literature, a retrospective oocyte donor model and a prospective
trial with IVF/ICSI subjects both found no statistical difference
between endometrial disruption and no intervention [16, 17].
This study seeks to assess the impact of single pass endo-
metrial biopsy, termed endometrial disruption, in the sub-
group of patients at highest risk for an endometrial cause for
failed implantation: those who have failed to conceive after
the transfer of morphologically-normal, euploid embryos.
This population is difficult to manage and there are no clear
guidelines to improve outcomes after a failed euploid transfer.
To complete this analysis only those patients who failed to
sustain implantation despite the transfer of morphologically-
normal, euploid blastocysts were included. To determine
whether endometrial disruption was beneficial, the outcomes
in a subsequent transfer of euploid blastocysts were compared
between the group who underwent endometrial disruption and
those who did not.
Materials and methods
Study population
This was a retrospective analysis of all patients less than
42 years old who failed to deliver after their first euploid
blastocyst transfer and subsequently completed a second
transfer cycle of euploid blastocysts at the study center be-
tween 2010 and 2014. Both fresh and frozen transfer cycles
were included. Patients were stratified into two groups: those
who had endometrial disruption performed preceding their
second embryo transfer (study group) and those who did not
have this procedure performed (control group). Demographic
information was collected and the most common diagnosis
was male factor (21 %), with the distribution of diagnoses
included in Table 1. ICSI was performed in all cases, as is
necessary for CCS, possibly reducing the impact of male fac-
tor diagnoses recorded in this study. Five patients were cate-
gorized with uterine factor and in all cases the uterine anomaly
was significant for fibroids that did not impact the endometrial
cavity. The groups were similar in overall characteristics ex-
cept that the group with no intervention was slightly older
(33.9±4.0 vs. 35.5±4.0, p=0.02). While this difference was
statistically significant, it is not thought to be clinically
relevant given that increasing age correlates with
diminishing ovarian reserve and increasing aneuploidy
prevalence, which were controlled for with the transfer
of only euploid blastocysts. Additionally, patients had
equivalent sonographic markers of endometrial develop-
ment as measured by endometrial thickness (8.4±1.6 mm
vs. 8.8±2.0 mm, p=0.66) (Table 2).
All stimulation and embryology techniques were per-
formed as per routine practice standards. All embryos were
cultured to the blastocyst stage of development regardless of
size or quality of the cohort. All expanded blastocysts with a
discernible inner cell mass underwent trophectoderm biopsy
for Comprehensive Chromosome Screening (CCS) analysis
on day 5 or 6 of embryo development. The morphological-
ly-best, euploid embryo(s) were selected for transfer in all
cycles. Fresh transfers were performed on the morning of
day 6. Frozen transfers were performed in the afternoon of
the sixth day of progesterone exposure, typically in the form
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of 50 mg intramuscular progesterone in oil. Fresh and frozen
embryo transfer cycles were included as both techniques have
equivalent pregnancy outcomes in the study center [3]. The
decision on transfer order was based upon number and quality
of euploid blastocysts available, demographic factors includ-
ing patient age and prior history, patient preference, and guid-
ance from the primary physician and clinical team. No more
than two blastocysts were transferred in any cycle. Prior to
retrieval and as per routine practice standards, uterine cavity
evaluation was performed via saline-infusion sonogram (SIS)
documenting no intrauterine pathology. This procedure is per-
formed with a small flexible intrauterine insemination catheter
(Rocket Duo; Rocket Medical, Hingham, MA) proceeding
retrieval, and is only repeated in between transfer cycle one
and two if the patient experienced a miscarriage of a clinically
visible pregnancy on ultrasound.
Technique of endometrial disruption
Due to the retrospective nature of the study design, a single
pass endometrial biopsy, termed endometrial disruption was
performed in cycles at the recommendation of the primary
clinician. During the time period between 2010 and 2014 the
technique of endometrial disruption was standardized at the
study center and therefore comparable between clinicians and
cycles. This procedure was performed via an endometrial cell
sampler (Endocell; Wallach, Trumbull, CT) in the luteal phase
of the menstrual cycle and was accomplished in the 1–2 cycles
prior to embryo transfer. After introducing the catheter into the
uterine cavity and withdrawing the piston, a single pass biopsy
was performed. In this way, the procedure was low in cost, a
minor intervention, and performed in the outpatient setting.
Tissue collected was discarded and no further analysis was
performed.
Embryo transfer and follow-up
Embryo transfer was performed as per practice standards with
an endometrial thickness of at least 6 mm documented in the
transfer cycle of interest. Clinical implantation (clinical IR)
was defined as the maximum number of gestational sacs per
embryo transferred and sustained implantation (sustained IR)
by the number of fetal heartbeats at discharge (approximately
8–9 weeks of gestation) per embryo transferred. A clinical
miscarriage was defined as the loss of a pregnancy after visu-
alization of a gestational sac.
Table 2 Demographic
information, cycle characteristics,
and embryology outcomes in
patients who failed their first
euploid embryo transfer and
subsequently completed a second
euploid embryo transfer
Parameters Endo Disruption (N=39) (±SD) No Intervention
(N=251) (±SD)
p value
Mean adjusted age (years) 33.9±4.0 35.5±4.0 0.02
Mean highest D3 FSH (IU/L) 8.1±2.8 9.2±6.7 0.66
Mean baseline antral follicle count 19.9±12.1 16.9±9.7 0.13
Mean endometrial thickness at transfer (mm) 8.4±1.6 8.8±2.0 0.66
Number of frozen cycles 38 (97.4 %) 237 (94.4 %) 0.43
Mean count of mature oocytes retrieved 12.8±5.9 12.9±7.1 0.63
Mean count of blastocysts biopsied 6.6±4.4 5.7±3.8 0.23
Mean count of euploid blastocysts transferred 1.5±0.6 1.4±0.5 0.16
Mean count of blastocysts cryopreserved 4.8±3.4 4.3±3.1 0.45
Table 1 Distribution of
diagnoses in patients with one
failed euploid blastocyst transfer
who subsequently completed a
second transfer cycle of euploid
blastocysts
Diagnosis No intervention N (%) Endometrial disruption N (%) All patients N (%)
Combined male/Female 29 (12 %) 3 (8 %) 32 (11 %)
Diminished ovarian reserve 12 (5 %) 1 (3 %) 13 (4 %)
Endometriosis 10 (4 %) 2 (5 %) 12 (4 %)
Genetic 14 (6 %) 2 (5 %) 16 (6 %)
Male factor 54 (22 %) 8 (21 %) 62 (21 %)
Other factor 39 (16 %) 8 (21 %) 47 (16 %)
Ovulatory dysfunction 48 (19 %) 8 (21 %) 56 (19 %)
Tubal factor 16 (6 %) 1 (3 %) 17 (6 %)
Unknown factor 24 (10 %) 6 (15 %) 30 (10 %)
Uterine factor 5 (2 %) 0 (0 %) 5 (2 %)
Total patients 251 39 290
J Assist Reprod Genet (2015) 32:557–562 559
Statistical analysis
Data analysis was performed via Analyse-it for Excel version
2.30. Categorical data were analyzed using Chi square to com-
pare outcomes between groups. Continuous variables are pre-
sented as a mean±SD andwere analyzed byMann-WhitneyU
Tests. Statistical significance determined for p value <0.05.
This retrospective analysis was IRB approved by Western
IRB, protocol # 20021333.
Results
In total, 290 patients who had failed their first euploid embryo
transfer and subsequently completed a second euploid embryo
transfer were identified and included for analysis. Each cycle
was then analyzed to determine if endometrial disruption was
performed in between transfer cycle 1 and cycle 2. Of all
included patients, 39 (13 %) patients underwent endome-
trial disruption prior to their second euploid embryo trans-
fer and 251 did not undergo this procedure. Of the 39
patients who underwent endometrial disruption, 32
(82 %) patients had the procedure performed within one
menstrual cycle prior to transfer, and 7 (18 %) patients
had the procedure performed within two menstrual cycles
prior to transfer.
A total of 403 euploid embryos were transferred, with an
average of 1.4 embryos transferred per patient. There was no
statistical difference between transfer order between groups;
51.3 % in the endometrial disruption group and 63.2 % in the
control group were single embryo transfers (N=20, N=158;
p=0.16). Most included procedures were frozen embryo
transfers, 97.4 % in the endometrial disruption group and
94.4 % in the control group, (N=38, N=237; p=0.48). This
can likely be attributed to the fact that supernumerary euploid
embryos that were cryopreserved after a fresh cycle were
transferred in the subsequent frozen cycle. The overall clinical
implantation rate was 53.4 % and sustained implantation rate
was 42.1 %. There were no statistical differences in clinical
implantation between the group with endometrial disruption
and the control group (43.6 % vs. 55.0 %, p=0.13) (Fig. 1).
Similarly, there was no difference between these groups in
sustained implantation rates (38.5 % vs. 42.6 %, p=0.60).
The overall incidence of miscarriage was also not statistically
different between groups (5.1 % vs. 12.4 %, p=0.60). The
mean age or transfer order did not differ between cycles
resulting in a pregnancy and those that were unsuccessful.
When fresh transfers were excluded, and only frozen cycles
were analyzed, there were no statistical differences noted in
clinical implantation, sustained implantation, or miscarriage
rates between groups (42.1 % vs. 55.5 %, p=0.06; 36.8 %
vs. 43.2 %, p=0.33; 5.3 % vs. 12.2 %, p=0.15).
In the subgroup analysis, single and double embryo trans-
fers were evaluated separately. In the investigation of single
embryo transfers, no statistical differences was noted in clin-
ical implantation rates between the group with endometrial
disruption, and subjects without this procedure (45.0 % vs.
55.7 %, p=0.38). Similarly no significant difference was not-
ed in the analysis of double embryo transfers (42.1 % vs.
53.8 %, p=0.20).
A power analysis was performed to reflect the statistical
impact suggested by the aforementioned meta-analysis where
endometrial injury performed in the cycle preceding ovarian
stimulation was 70 % more likely to result in a clinical
pregnancy [4]. This study had a 97 % power to detect
the same impact in pregnancy rates, but found no such
difference. Furthermore, this analysis included only high-
quality, euploid blastocysts, thereby minimizing the variable
of embryonic quality.
P=0.13Fig. 1 Clinical Implantation Rateis not significantly different
between groups studied
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Discussion
In the present retrospective study, endometrial disruption per-
formed with a single pass endometrial biopsy did not improve
pregnancy or sustained implantation rates in women who had
previously failed the transfer of morphologically normal eu-
ploid blastocysts. The significant advantage of this study is the
inclusion of only morphologically-normal, euploid blasto-
cysts, thereby neutralizing many of the embryonic factors that
could influence IVF outcomes. Identifying this high-risk sub-
group for study is particularly impactful to clinical care as
these are the patients who are offered investigational tech-
niques with limited evidence to support them. Unfortunately
this subgroup of patients still remains a challenging clinical
dilemma as no improvement in outcome was seen with endo-
metrial disruption.
Recent literature has demonstrated a potential improve-
ment in clinical pregnancy and live birth rates with the use
of endometrial disruption in the cycle proceeding IVF. It is
plausible that the wound healing process may be provoked
with endometrial injury and this can induce the release of
immunomodulators that directly impact implantation [18].
Furthermore, this technique has been shown to upregulate
genes important in implantation and endometrial receptivity
[19]. Current literature is widely disparate onwhether or not to
recommend this treatment modality to patients, with conclu-
sions ranging from marked improvement, no difference de-
tected to a potentially-negative impact [4, 6, 16, 20]. Conse-
quently the strength of this study is that it targets the subgroup
of patients most likely to benefit from this treatment strategy,
those who fail to deliver after the transfer of morphologically-
normal euploid blastocysts.
For this same reason, the present analysis is not directly
applicable to the general IVF population and this is a limita-
tion of the study design. The theory of disrupting the endome-
trium in the cycle preceding transfer may still hold merit for
other populations; however, in a recent prospective analysis
targeting the general IVF population no such benefit was seen
[17]. It is possible that a more aggressive approach to endo-
metrial injury may be warranted in this population or that
direct visualization with hysteroscopy may confer additional
benefits as opposed to an outpatient single-pass biopsy. Fur-
ther, it is possible that more than one cycle of endometrial
injury may be necessary or the time span between biopsy
and transfer may need to be adjusted. In this study endometrial
disruption was only included if performed in the 1–2 cycles
proceeding embryo transfer. In one analysis, benefit was
found when endometrial disruption was as far removed as
6 cycles prior to transfer, however the optimal window of
disruption has yet to be determined [21].
The limited sample size and the high incidence of frozen
transfers may be confounding variables in this analysis. For
this reason a separate analysis was performed documenting no
difference in outcomes for frozen cycles. The high proportion
of frozen transfers included in this study may have impacted
outcomes as this may represent an exclusion of patients who
did not have supernumerary euploid blastocysts available for
transfer in a subsequent cycle. Additionally, it may have been
useful to analyze the biopsy results for histopathologic diag-
nosis, potentially providing more information to direct cycle
management. As a result of the retrospective nature of this
study design, we cannot exclude the possibility that women
who underwent endometrial disruption could have been an
even poorer prognosis group then those who did not and sub-
sequently underwent this procedure at the recommendations
of the clinical team. However, it is reassuring to note that both
populations had equivalent demographic parameters and cycle
dynamics, even with the potential for a slighter poorer prog-
nosis in the intervention group, given the older age of these
patients. All patients in this study had a saline infusion sono-
gram to document a normal intrauterine cavity prior to embryo
transfer and while there has not been evidence suggesting this
procedure alters the endometrial environment, it could theo-
retically be a confounding variable to study design.
Implantation failure is a challenging clinical dilemma and
both the embryo and endometrium play critical roles in estab-
lishing a successful pregnancy. Recent advances in blastocyst
culture and genetic screening have allowed for selection of the
highest-quality embryos; however, tools that can enhance en-
dometrial receptivity are still under investigation. This is the
first analysis that addresses the impact of endometrial disrup-
tion in the highest-risk subgroup: those who have previously
failed the transfer of morphologically–normal, euploid
blastocysts.
Single pass endometrial biopsy has no measurable impact
on endometrial receptivity in the highest risk subgroup -
patients who have failed to sustain the transfer of morpholog-
ically normal euploid embryos- as evidenced by equivalent
clinical and sustained implantation rates. While it remains
possible that the etiology of the failures may relate to embryo
quality in spite of rigorous efforts to identify morphologically-
normal, euploid embryos, these data suggest that caution
should be used prior to adopting endometrial disruption and
that class I data evaluating specific well-defined clinical situ-
ations are still needed. Specifically, a randomized controlled
trial evaluating live birth outcomes following endometrial dis-
ruption in the cycle immediately preceding fresh or frozen
euploid blastocyst transfers is needed to determine the clinical
efficacy of this strategy in patients who fail to sustain implan-
tation of the highest-quality embryos.
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